Atezolizumab and Bevacizumab's Function in Treating Liver Cancer

Atezolizumab and Bevacizumab's Function in Treating Liver CancerПодробнее

Atezolizumab and Bevacizumab's Function in Treating Liver Cancer

Real-world outcomes of patients with HCC treated with lenvatinib vs. atezolizumab plus bevacizumabПодробнее

Real-world outcomes of patients with HCC treated with lenvatinib vs. atezolizumab plus bevacizumab

Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinomaПодробнее

Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

Will atezolizumab and bevacizumab be the new SOC in high-risk HCC?Подробнее

Will atezolizumab and bevacizumab be the new SOC in high-risk HCC?

Outcomes with multikinase inhibitors after progression on first-line atezolizumab-bevacizumab in HCCПодробнее

Outcomes with multikinase inhibitors after progression on first-line atezolizumab-bevacizumab in HCC

Atezolizumab + Bevacizumab in Treatment-Naïve mRCCПодробнее

Atezolizumab + Bevacizumab in Treatment-Naïve mRCC

Richard S. Finn, MD, offers opinion on the role of frontline atezolizumab + bevacizumab in HCCПодробнее

Richard S. Finn, MD, offers opinion on the role of frontline atezolizumab + bevacizumab in HCC

Recent immunotherapy advances in HCC managementПодробнее

Recent immunotherapy advances in HCC management

IMbrave050: adjuvant atezolizumab with bevacizumab in high-risk HCCПодробнее

IMbrave050: adjuvant atezolizumab with bevacizumab in high-risk HCC

Atezolizumab and bevacizumab for upfront unresectable HCCПодробнее

Atezolizumab and bevacizumab for upfront unresectable HCC

Combination Atezolizumab Plus Bevacizumab Improved Quality of Life in HCCПодробнее

Combination Atezolizumab Plus Bevacizumab Improved Quality of Life in HCC

Dr. Kaseb on Safety Profile of Atezolizumab Plus Bevacizumab in HCCПодробнее

Dr. Kaseb on Safety Profile of Atezolizumab Plus Bevacizumab in HCC

Richard S. Finn, MD, tells us about the safety profile of atezolizumab & bevacizumab from IMbrave150Подробнее

Richard S. Finn, MD, tells us about the safety profile of atezolizumab & bevacizumab from IMbrave150

Dr. Rini Discusses Atezolizumab Plus Bevacizumab in RCCПодробнее

Dr. Rini Discusses Atezolizumab Plus Bevacizumab in RCC

First-line Atezolizumab With Bevacizumab for HCCПодробнее

First-line Atezolizumab With Bevacizumab for HCC

Dr. Overman on the Combination of Atezolizumab and Bevacizumab in HCCПодробнее

Dr. Overman on the Combination of Atezolizumab and Bevacizumab in HCC

Dr Bharat | Role of Tecentriq Atezolizumab + Avastin Bevacizumab As 1L in Unresectable HCCПодробнее

Dr Bharat | Role of Tecentriq Atezolizumab + Avastin Bevacizumab As 1L in Unresectable HCC

What are possible side effects associated with bevacizumab and atezolizumab for liver cancer?Подробнее

What are possible side effects associated with bevacizumab and atezolizumab for liver cancer?

Dr. Pishvaian Discusses Atezolizumab Plus Bevacizumab in HCCПодробнее

Dr. Pishvaian Discusses Atezolizumab Plus Bevacizumab in HCC

PD-1/VEGFR blockade for liver cancerПодробнее

PD-1/VEGFR blockade for liver cancer